A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of a First-in-Human Engineered Cationic Peptide, PLG0206, Intravenously Administered in Healthy SubjectsDavid Huang & Despina Dobbins & Parviz Ghahramani & Ian Friedland & Jonathan Steckbeck2022PDF548 KBEN